ライフサイエンスコーパス: decoy

1 a dominant-negative inhibitor of IGF1R (IGF1 decoy).

2 tream (eg, aurora-kinase inhibitors and STAT decoys).

3 han other incorrect glycopeptide candidates (decoys).

4 ze the ligand-mediated damage by acting as a decoy.

5 active when the chosen option dominated the decoy.

6 been shown to function as an APRIL-specific decoy.

7 the native state with respect to structural decoys.

8 ber of near-native poses found among the top decoys.

9 first MSMs out of all MetaCyc metabolites as decoys.

10 emains ligand enrichment against challenging decoys.

11 of competitor DNA duplexes, including Egr-1 decoys.

12 igands form more-resilient interactions than decoys.

13 nRNP L sequesters miR-574-3p, overcoming its decoy activity and seed sequence-dependent gene silencin

14 as been benchmarked widely on a large set of decoys, all models generated at the seventh worldwide ex

15 DNA methylation of decoys alone did not affect target search kinetics.

16 The decoys, along with target glycopeptides, are scored agai

17 thasone, inhibition of miR-433 using a tough decoy altered the period and amplitude of Per2 gene expr

18 the role of CP(169-180) as an immunological decoy and illustrate the importance of the structural fo

19 ry rate of ~ 5% as estimated by naive target-decoy and MAYU approaches, signifying a 6-fold increase

20 nstrates the dependence of preference on the decoy and on the context in which the options are presen

21 ated neutralization by serving as an antigen decoy and to inhibit the antibody-mediated antiviral eff

22 targets available in the Directory of Useful Decoys and the performance was evaluated using the area

23 ormance of ROTAS was tested using 13 sets of decoys and was compared to those of existing atomic-leve

24 of dabigatran, the investigational factor Xa decoy andexanet alfa, and the synthetic small molecule c

25 eral HIV-protease inhibitors can function as decoy antigens to specifically inhibit the binding of an

26 ve flexibility, producing new small-molecule decoy antigens, which neutralize anti-dsDNA antibodies i

27 lenge is usually addressed by using a Target-Decoy Approach (TDA) to impose an empirical False Discov

28 orithm shown to be compliant with the target-decoy approach (TDA).

29 This "decoy" approach may be applicable to other NLR proteins

30 These results suggest that when decoys are methylated, MBD proteins can block them and t

31 n-native protein structure conformations (or decoys) are often used for designing protein folding sim

32 vior, whereby males fly to and alight on the decoys as they would on real females.

33 TF, can employ an exhaustive sampling during decoy assembly.

34 We present empirical Bayes and target-decoy based methods to estimate the false discovery rate

35 We show that the standard method of decoy-based error modeling fails to account for the erro

36 spatial information to inhibit selecting the decoy beacon, despite knowing the platform's actual spat

37 In normoxia, miR-574-3p, acting as a decoy, binds cytoplasmic hnRNP L and prevents its bindin

38 orithm, 3DRobot, to create protein structure decoys by free fragment assembly with enhanced hydrogen-

39 ; however, with the addition of an inferior "decoy" C, females reversed their preferences and chose A

40 effect": introducing an irrelevant option (a decoy) can influence choices among other (relevant) opti

41 Combining decoy cell and BK viremia in a diagnostic matrix improve

42 [PCR]) and BK viruria (quantitative PCR and decoy cell counts).

43 t to conventional quantitative PCR assays or decoy cell counts, quantitative urinary PV-Haufen testin

44 No correlations were seen with urinary decoy cell counts.

45 erformance of quantitative viremia surpassed decoy cells (area under the curve of 0.95 and 0.79, resp

46 d the diagnostic test performance of urinary decoy cells and urinary SV40T immunochemistry of exfolia

47 Although quantified decoy cells are acceptable surrogate markers of BK viral

48 Quantification of decoy cells improved the PPV to 32.1% (10 >/= cells thre

49 Decoy cells occurred in 95 of 704 (13.5%) samples, with

50 protein abundance was unaffected in miR-433 decoy cells.

51 phropathy, any urine cytology demonstrating "decoy" cells, and/or significant polyomavirus BK viremia

52 dent and is likely to be mediated via the D6 decoy chemokine receptor.

53 Recent studies have shown that non-signaling decoy chemokine receptors bind and modulate the expressi

54 sify models as correct/incorrect; discarding decoys classified as incorrect led to an enrichment in t

55 discriminate the near-native structures from decoy complexes and at the same time make conformational

56 he learning task further improves the target-decoy database analysis for identifying peptides, which

57 The target-decoy database strategy is largely used for error estima

58 rget-decoy strategy in proteomics, employs a decoy database that is created based on the target prote

59 in identifying glycopeptides without using a decoy database.

60 er >98% of native-like models of CcdB from a decoy dataset.

61 olution of modern mass spectrometers, target-decoy derived FDRs can diminish.

62 refinement of membrane protein models and in decoy discrimination.

63 Expression of the IQGAP1-IQ motif decoy domain in epidermal tissue in vivo inhibits oncoge

64 a-RGA5 interaction and the role of the RATX1 decoy domain of RGA5.

65 ent defense, and RPS4/RRS1 has integrated a "decoy" domain that enables detection of effectors that t

66 red plant immune receptors have incorporated decoy domains that structurally mimic pathogen virulence

67 advantage, of the combination of integrated decoy domains with additional independent effector-NLR i

68 Whereas the directory of useful decoys (DUD) has been widely used, clear areas for optim

69 atum when subjects successfully overrode the decoy effect and made unbiased choices.

70 results suggest that the neural basis of the decoy effect could be the context-dependent activation o

71 o investigate the neural underpinning of the decoy effect of both sexes.

72 exhibit a violation of rationality known as "decoy effect": introducing an irrelevant option (a decoy

73 lausible neuronal model that can account for decoy effects based on the trial-by-trial adjustment of

74 We find within-subject decoy effects similar to what have been shown previously

75 the influence of the choice set size on the decoy effects, which are in contrast to previous models

76 a novel experiment to measure within-subject decoy effects.

77 coloration mechanism, the nano-bioreplicated decoys evoked the complete attraction and landing sequen

78 a metabolite-signal match score and a target-decoy FDR estimate for spatial metabolomics.

79 , in part, to the deployment/secretion of a "decoy flare," for example, anomalous cancer-associated a

80 MutY possesses an exo-site that serves as a decoy for C, and secondly, repulsive forces with a key a

81 I) into productive elongation by acting as a decoy for the negative elongation factor (NELF) complex

82 ods for automated generation of high-quality decoys for any target proteins.

83 tion transgenic mice overexpressing microRNA decoys for either miR-23a or miR-27a, but not miR24-2, s

84 al penton-dodecahedral particles that act as decoys for HD5, thus preventing the inactivation of viru

85 t retrotransposon-derived transcripts act as decoys for miR171, triggering its degradation and thus r

86 mmatory signaling receptor, sRAGE acts as a "decoy" for RAGE ligands and prevents their interaction w

87 debranching activity and, hence, represent "decoys" for sequestering RNA binding proteins thought to

88 es and the ratio of the number of targets to decoys, for small data sets.

89 ResQ was further tested on structure decoys from CASP9-11 experiments, where the error of loc

90 TMEM219 also contributed to the decoy function of IL-13Ralpha2.

91 ng NKR-P1A/C receptors to counterbalance m12 decoy function.

92 ased sTACI is an immunoregulator that shares decoy functions with atacicept.

93 The decoys generated by 3DRobot are shown to have significan

94 GPE generates decoy glycopeptides de novo for every target glycopeptid

95 lation further limits the number of possible decoy glycopeptides tested in a database search.

96 Substituents placing polar decoy groups into the pocket to capture putatively prese

97 ble to identify eight cases where no correct decoy had been generated.

98 vely generate a model to classify PSMs using decoy hits with increased sensitivity.

99 Mice treated with decoy IL-21 receptor Fc fusion protein are protected fro

100 aria of transgenic mice expressing a miR-433 decoy in osteoblastic cells (Col3.6 promoter), the ampli

101 c toxin nanosponge that functions as a toxin decoy in vivo.

102 ere verified by shining a white laser on the decoys in a dark room and projecting the scattering patt

103 approach to discriminating native poses from decoys in difficult targets for which several scoring fu

104 d to an enrichment in the proportion of good decoys in our final ensemble by a factor of seven.

105 y active immunoreceptors, ligands, and viral decoys, including challenging cell surface proteins that

106 bition of DLL1/4 with ligand-specific Notch1 decoys increased sprouting of sinusoidal endothelial cel

107 nown receptor-selective ligands from related decoys, indicating a high degree of precision in pocket

108 Finally, we show that the miRNA decoy library can be used for pooled loss-of-function st

109 r functional analysis of microRNA (miRNA): a decoy library for inhibiting miRNA function and a sensor

110 MV genome encodes for MHC class I-homologous decoy ligands for inhibitory NK cell receptors to evade

111 yers containing different levels of anionic 'decoy' lipids.

112 LSTc decoy liposomes co-localize with fluorescently tagged in

113 Decoy liposomes competitively bind influenza virus in he

114 LSTc-bearing decoy liposomes form multivalent, polymer-like interacti

115 teractions with influenza hemagglutinin, our decoy liposomes have potential as a new therapeutic agen

116 LSTc decoy liposomes prevent the spread of influenza virus du

117 agglutinin binding pocket and the ability of decoy liposomes to form high avidity interactions with i

118 calculated accurately based on the number of decoy matches and the ratio of the number of targets to

119 d ability to recognize native structure from decoy models compared to other potentials.

120 nd therefore, TAR may be a dominant negative decoy molecule in cells.

121 osteocalcin, were also increased in miR-433 decoy mouse calvaria.

122 using various techniques including receptor decoys, multiple co-operative binding sites, and sequent

123 lectively, our findings identify a molecular decoy naturally generated during apoptosis that inhibits

124 ch signaling, or its acute inhibition with a decoy Notch1 receptor, prevents hepatosteatosis by block

125 er, other hypotheses including virus-induced decoy of the immune system also warrant discussion in re

126 We used nano-bioreplicated visual decoys of female emerald ash borer beetles (Agrilus plan

127 r mRNA splicing and translation by acting as decoys of RNA-binding proteins or microRNAs and can comp

128 With field experiments using predator decoys of the black grouper (Mycteroperca bonaci), we in

129 eport the development of an engineered STAT3 decoy oligodeoxynucleotide (dODN) that is stable in seru

130 Moreover, pretreatment of the cells with a decoy oligonucleotide carrying wild-type p53-response el

131 ucleotide to restore SMN and a complementary decoy oligonucleotide to neutralize its effects in the C

132 hich AP-1 and IkappaB were down-regulated by decoy oligonucleotides and siRNA, suggest that the morph

133 ned the kinetic impact of DNA methylation of decoys on the search process of the Egr-1 zinc-finger pr

134 novel mechanism by which ROR may serve as a decoy oncoRNA that blocks binding surfaces, preventing t

135 t with the hypothesis that the presence of a decoy option influences the valuation of other options,

136 inds to IL-13Ralpha2, considered as either a decoy or a key mediator of fibrosis.

137 d by Pii, suggesting a role for OsExo70 as a decoy or helper in Pii/AVR-Pii interactions.

138 DNA binding (e.g., with oligodeoxynucleotide decoys or pyrrole-imidazole polyamides) has demonstrated

139 These decoys outcompete host cell receptors by preferentially

140 The TRAF6 decoy peptide blocked both LPS-induced SFK ubiquitinatio

141 A cell-permeable decoy peptide corresponding to the same proline-rich mot

142 tion of HMVEC-Ls with a cell-permeable TRAF6 decoy peptide decreased both LPS-induced SFK activation

143 A decoy peptide design based on this FLV motif could block

144 A decoy peptide disrupting the IL-17RA-NOTCH1 interaction

145 ts could be rescued by the treatment of this decoy peptide in both M17 cells overexpressing D620N or

146 we investigated the degree to which TLR TIR decoy peptide modified to include a TAT sequence (Trans-

147 Using a decoy peptide representing the Ca(2+)/calmodulin kinase

148 Decoy peptide spanning HDAC1 K74 and RG 7112, an MDM2 in

149 define the binding site, we used a series of decoy peptides derived from the primary amino acid seque

150 A library of cell-permeating decoy peptides derived from TRAM TIR domain has been scr

151 FLNa interaction in neurons, with the use of decoy peptides that mimic the FLNa-binding domain of HCN

152 e have now expanded this study to test TIRAP decoy peptides.

153 the native (or nativelike) binding pose from decoy poses that cannot be distinguished using scoring f

154 ding poses is distinctly longer than that in decoy poses.

155 t) is a recombinant modified human factor Xa decoy protein that has been shown to reverse the inhibit

156 Hence, decoy proteins encoding only a CARD or PYD, COPs and POP

157 ery target glycopeptide, in a 1:20 target-to-decoy ratio.

158 We have used a soluble ActRIIB decoy receptor (ACVR2B/Fc) to test the effects of myosta

159 affinity bias of IL-1Ra for IL-1R1 over the decoy receptor (IL-1R2), and, surprisingly, is also more

160 The decoy receptor 3 (DcR3) competes for TL1A binding and in

161 Decoy receptor 3 (DcR3) is a soluble protein in the TNFR

162 binds to a secreted TNF family member called decoy receptor 3, which interferes with the interaction

163 operties required the engagement of the IL-1 decoy receptor 8 (IL-1R8) and the activation of AMP-acti

164 However, CCX-CKR acts as decoy receptor and efficiently internalizes these chemok

165 h neutralizing antibodies or the soluble IFN decoy receptor B18R nor by short hairpin RNA (shRNA) kno

166 Addition of a neutralizing type I IFN decoy receptor blocked the expression of IRF7 and IL-12p

167 sMerTK acts as a decoy receptor blocking the effect of both MerTK ligands

168 e illustrate how GIF serves as a competitive decoy receptor by leveraging binding hotspots underlying

169 iants that bind to the neutrophil-restricted decoy receptor CEACAM3.

170 By this route, we defined the decoy receptor DcR1 as a temozolomide response gene indu

171 xpression patterns, confirming its role as a decoy receptor for IL-13 signaling.

172 luble protein (sST2) that is thought to be a decoy receptor for IL-33 signaling.

173 In contrast, soluble ST2 appears to act as a decoy receptor for IL-33, blocking myocardial and vascul

174 OPG is a decoy receptor for RANKL, thereby increasing BMD.

175 ernative to the widely used BAFF receptor-Fc decoy receptor for the specific depletion of BAFF in mic

176 pression of CyHV-3 ORF12, encoding a soluble decoy receptor for TNF-alpha, delayed the manifestation

177 ulated transcripts is TRAILR4 that encodes a decoy receptor for TRAIL-a pro-apoptotic cytokine that i

178 ring ischaemia, soluble CD163 functions as a decoy receptor for TWEAK, a secreted pro-inflammatory cy

179 loyed by poxviruses, encoding four viral TNF decoy receptor homologues (vTNFRs) named cytokine respon

180 pecific receptor antagonist (IL-1Ra) and the decoy receptor IL-1 receptor type 2 (IL-1R2).

181 We have previously shown that the decoy receptor IL-13 receptor (IL-13R) alpha2 attenuates

182 IL-13 saturated fraction of the circulating decoy receptor IL-13Ralpha2.

183 Our data demonstrate that the decoy receptor IL-1R2 plays an important inhibitory role

184 a suggest that FGFRL1 does not function as a decoy receptor in beta-cells, but rather it enhances ERK

185 It functioned as a decoy receptor inhibiting BAFF- and APRIL-mediated B cel

186 Here, we show that the D6 chemokine decoy receptor is constitutively expressed by primary hu

187 erleukin-1 receptor type 2 (IL1R2) acts as a decoy receptor of exogenous IL-1; however, its intracell

188 NF-kappaB, its ligand RANKL, and the soluble decoy receptor osteoprotegerin are the key regulators of

189 ing ligand, in conjunction with their shared decoy receptor osteoprotegerin, in the bone marrow of in

190 Osteoprotegerin (OPG), a decoy receptor secreted by osteoblasts, is a major negat

191 adial glia control this process via the Vegf decoy receptor sFlt1: sflt1 mutants exhibit the venous o

192 pha chain, or treatment with a soluble IL-33 decoy receptor significantly reduced release of inflamma

193 Both IL-33 effector function, via its decoy receptor sST2, and Col3 synthesis are regulated by

194 treatment of CD patients with etanercept, a decoy receptor that binds soluble TNF, fails to improve

195 ments, IFN-alphabeta was neutralized using a decoy receptor that blocks IFN signaling, whereas specif

196 The first is a decoy receptor that competes for activating ligands.

197 1 (mVEGFR1) is an endothelial cell-intrinsic decoy receptor that negatively modulates blood vessel mo

198 ains, FGFRL1 has been postulated to act as a decoy receptor to inhibit canonical FGFR ligand-induced

199 The GDNF and the TNFR decoy receptor were re-engineered for BBB transport as I

200 ering a second-generation, high-affinity AXL decoy receptor with an apparent affinity of 93 femtomola

201 orm of IL23R mRNA (which then functions as a decoy receptor) and lowers the ability to develop a Th17

202 f WT mice with soluble IL-33 receptor (IL-33 decoy receptor) markedly reduced CCI-induced hyperalgesi

203 n primary ASMC migration and the role of the decoy receptor, Duffy AgR for chemokines (DARC), in this

204 aintained at pH 6.2, but the activity of the decoy receptor, IL-1R2, is reduced.

205 ed by infiltration with cells expressing the decoy receptor, IL-1R2.

206 Our decoy receptor, MYD1-72, profoundly inhibited disease pr

207 mammalian CXCR7, the most recently described decoy receptor, results in postnatal lethality due to ab

208 The CD40 decoy receptor, sCD40R, may serve as a potential therape

209 encoding both the IL-33 receptor, ST2L, and decoy receptor, sST2, has been genetically associated wi

210 -ED into the airway lumen as a hyperadhesive decoy receptor.

211 ype II tumor necrosis factor receptor (TNFR) decoy receptor.

212 ot internalize PGRN, essentially acting as a decoy receptor.

213 t1 (VEGFR1), a VEGFA receptor that acts as a decoy receptor.

214 though whether CXCR7 acts as a signaling or "decoy" receptor has been in debate.

215 Our data indicate sCD48 as a SEB-induced 'decoy' receptor derived from eosinophil and therefore as

216 Serving as decoys, receptor mimics may lessen symptoms while avoidi

217 The inhibitory decoy receptors (DcR1 and DcR2) co-expressed with death

218 rming four signaling receptor complexes, two decoy receptors (IL-1R2, IL-18BP), and two negative regu

219 eveal a previously underappreciated role for decoy receptors as molecular rheostats in controlling th

220 R signaling and suggest that they can act as decoy receptors for self-antigens that are recognized by

221 Structural and mechanistic studies of these decoy receptors have provided a wealth of information, n

222 ) 5 and DR4 but did not affect expression of decoy receptors in cancer cells.

223 Our results indicate that decoy receptors on soluble serum factors compete with ce

224 ion, and disruption of this interaction with decoy receptors or blocking Abs should mitigate disease

225 otein expression of TRAIL, DR5 and the TRAIL decoy receptors osteoprotegerin (OPG), mDcTRAILR1, and m

226 ection of cells, or alternatively can act as decoy receptors that bind virions and block virus infect

227 assembly, mimicking the biological effect of decoy receptors that lack the death domain to trigger ap

228 ulated that targeting the type I and type II decoy receptors used by poxvirus to subvert the host inn

229 ical 7-transmembrane receptors, often called decoy receptors, act promiscuously as molecular sinks to

230 xpression of soluble endogenous antagonists, decoy receptors, and posttranslational processing of bio

231 A tight regulation via receptor antagonists, decoy receptors, and signaling inhibitors ensures a bala

232 LR3 and TRAILR4 are generally referred to as decoy receptors, which have been shown to inhibit TRAIL-

233 eptors and thus are likely to be viral SLAMF decoy receptors.

234 ressed homolog of conserved FGFRL/nou-darake decoy receptors.

235 results show that OPUS-DOSP has an increased decoy recognition capability comparing with those of oth

236 in archival NSCLC samples, functioning as a decoy RNA for miR-339-3p, -663b-3p, and -95-5p.

237 ry rate estimation method, based on a target-decoy search approach, is derived for assigning confiden

238 Meanwhile, most protein decoy sets are pre-calculated and there is a lack of met

239 OPUS-DOSP was tested on 11 decoy sets commonly used for statistical potential bench

240 However, almost all the decoy sets currently used in literature suffer from unev

241 le to generate high-accuracy predictions and decoy sets enriched with near-native loop conformations,

242 ethod was benchmarked with three widely used decoy sets from ab initio folding and comparative modeli

243 rmations in the Rosetta and I-TASSER protein decoy sets.

244 selecting the native protein structures from decoy sets.

245 mic interactions was developed and tested on decoy sets.

246 SSOs bound to splicing regulatory motifs and decoy splice sites in primary transcripts revealed a mot

247 tion by RapZ of GlmZ and the closely related decoy sRNA, GlmY.

248 se train achieves a key rate comparable to a decoy-state QKD protocol, an often-used technique for la

249 ycopeptide analysis, adopted from the target-decoy strategy in proteomics, employs a decoy database t

250 Thus, this apoplastic decoy strategy may be widely used in Phytophthora pathos

251 ntification was performed employing a target-decoy strategy.

252 imination of native protein-DNA complex from decoy structures, and most importantly in rigid TF-DNA d

253 effective discrimination between native and decoy structures.

254 ng domain (MBD), however, DNA methylation of decoys substantially ( approximately 10-30-fold) acceler

255 We suggest that HK-II binds TORC1 as a decoy substrate and provides a previously unrecognized m

256 nhibition of RNA sensors, by providing viral decoy substrates for cellular kinase complexes, and thro

257 tationary phases (54 distinct systems and 16 decoy systems) in micellar electrokinetic chromatography

258 of adeno-associated virus expressing a Tough-Decoy targeting miR-26a prevents Smad down-regulation an

259 ng that such RNA transcripts may function as decoy targets or traps for NF-Y and thus inhibit the gro

260 We use these artificial liposomes as decoy targets to sequester bacterial toxins that are pro

261 The subunit decoy technique was used to show that the long-lived end

262 s, such as antisense or Transcription Factor Decoys (TFDs), have the potential to circumvent current

263 erexpression of a 5' stem-loop RNA molecular decoy that sequesters LARP6, prevented the ability of IG

264 Two types of decoys that lacked one or both of these elements were fa

265 ogenic trickery using exogenously introduced decoys that present high-affinity mimics of cellular rec

266 ortant to fully characterize, as they may be decoys that promote nonneutralizing responses and may al

267 ions is an ability to act as scaffolds or as decoys that recruit or sequester effector proteins from

268 em by viruses is often mediated by molecular decoys that sequester host proteins pivotal to mounting

269 These sequences potentially serve as natural decoys that sequester transcription factors.

270 mycin-resistance by functioning as molecular decoys that titrate the antibiotic away from its intrace

271 perception and early signalling machinery to decoy the plants defence systems.

272 By acting as macrophage decoys, these nanoparticles bind and neutralize endotoxi

273 anti-inflammatory therapies based on soluble decoy TNFRs.

274 graminicola coopts the plant BR pathway as a decoy to antagonize effectual SA- and GA-mediated defens

275 e herbivore exploits symbiotic bacteria as a decoy to deceive plants into incorrectly perceiving the

276 d with increasing distance from the predator decoy to examine how herbivorous fishes reconcile the co

277 , upregulated during regeneration, acts as a decoy to inhibit PDGF signalling and to prevent FAP over

278 We hypothesize that ZED1 acts as a decoy to lure HopZ1a to the ZAR1-resistance complex, res

279 oncoding transcript that functions as an RNA decoy to sequester PKR in an inactive state.

280 mally degraded after splicing, likely act as decoys to sequester TDP-43 away from binding to and disr

281 ccumulate in the cytoplasm and likely act as decoys to sequester TDP-43, preventing it from interferi

282 e oligonucleotides, and transcription factor decoys to treat disease has prompted nearly 40 clinical

283 oduction of an irrelevant option (called the decoy) to a choice set does not change the preference be

284 h significantly reduced interaction with the decoy TRAIL receptors 3 and 4.

285 h during peak mosquito abundance, this "host decoy" trap caught nearly ten times the number of Anophe

286 of mHtt exclude chromatin and form 'sticky' decoy traps that impede target search processes of key r

287 Exactly how and why decoys trigger this effect is not known.

288 ed shRNAs via codelivery of inhibitory tough decoy (TuD) RNAs.

289 on of Notch, using a soluble receptor Notch1 decoy, unexpectedly caused a remarkable increase in live

290 In contrast, miR-181a inhibition via decoy vector suppression and Smad7 re-expression results

291 y injected with adenoviral vector encoding a decoy VEGF receptor (Ad-Flk) or a control adenovirus (Ad

292 tor tyrosine kinase inhibitors and a soluble decoy VEGF receptor have demonstrated nominal benefit am

293 that fishes foraging closest to the predator decoy were 40% smaller than those that foraged at furthe

294 ory response and of soluble RAGE acting as a decoy were associated with up-regulation of the DAMP-rel

295 The nano-bioreplicated decoys were also electroconductive, a feature used on tr

296 ed in a fragment assembly protocol to sample decoys, which are assessed by a composite scoring functi

297 hydrogen-bonding network and compactness of decoys, which eliminates the possibility of native struc

298 correct mutual orientation exist even in the decoys with a large overall root mean square deviation (

299 distinguishing these from 1065 approved drug decoys with an area under curve value of 99%.

300 ales made brief flying approaches toward the decoys without nanostructured features, but diverted awa